Northwestern University-led researchers have created the first highly mature neurons from human induced pluripotent stem cells (iPSCs), a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases and traumatic injuries.
Many neurodegenerative illnesses, including Alzheimer's and Parkinson's, are mostly caused by tau and tubulin proteins. The accumulation of these proteins in the brain is mostly responsible for the advancement of neurodegenerative diseases.
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published tod
Iron (Fe) accumulates in the brain cortex with aging. A plethora of studies indicate that progressive iron accumulation in the substantia nigra (SN) in the aged human brain is a major risk factor for Parkinson's disease (PD) and other neurodegenerative diseases, but not everyone. This is bec
Scientists have identified a drug that could be a game-changer for patients. Istradefylline, which is already approved for Parkinson's disease, could reduce not only the harmful effects of cisplatin but also improve its anti-tumour properties.
The study, published today in Nature, represents a comprehensive effort to characterize ASD at the molecular level. While neurological disorders like Alzheimer's disease or Parkinson's disease have well-defined pathologies, autism and other psychiatric disorders have had a lack of defining p
Chennai (Tamil Nadu) [India], October 20 (ANI/NewsVoir): Dr U Meenakshisundaram, Director and Senior Consultant, Neurology, SIMS Hospitals, Vadapalani, was recently invited by the International Congress of Parkinson's Disease and Movement Disorders Society as one of the eminent panellists, a
Washington [US], October 17 (ANI): Researchers at UVA Health have identified a brain chemical that coordinates the immune system's reactions to multiple sclerosis (MS) and Alzheimer's disease, potentially enabling medical professionals to boost the body's capacity to combat these and other d
Washington [US], September 30 (ANI): Researchers have used artificial intelligence to predict hospitalisation outcomes of geriatric patients with dementia on the first or second day of admission. Early outcome assessment means more timely interventions, better care coordination, more prudent
New York [US], September 21 (ANI): According to a new study led by Weill Cornell Medicine researchers, aggregates of the protein alpha-synuclein spread in the brains of people with Parkinson's disease via a cellular waste-ejection process.
Washington [US], September 16 (ANI): Infections treated with speciality hospital care in early and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), but not amyotrophic lateral sclerosis (ALS), according to a new study.